Related Experiment Video
Updated: Jul 17, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.4K
Investigating differences in young- and late-onset progressive supranuclear palsy
Batoul A AlWazan1,2, Indira Garcia-Cordero3, Blas Couto4
1Memory Clinic, Toronto Western Hospital, Toronto, ON, Canada. Batoul.Alwazan@medportal.ca.
Journal of Neurology
|September 5, 2023
Summary
Young-onset progressive supranuclear palsy (PSP) patients are more likely to exhibit speech and language deficits. Early age of onset may predict specific PSP phenotypes, offering clinical and prognostic insights.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Clinical Phenotyping
Background:
- The influence of age of onset on progressive supranuclear palsy (PSP) phenotypes remains underexplored.
- A hypothesis suggests distinct presentations between young-onset PSP (YOPSP) and late-onset PSP (LOPSP).
Purpose of the Study:
- To compare the clinical phenotypes and the rate of disability progression between YOPSP and LOPSP.
- To identify differences in presenting symptoms and diagnostic criteria fulfillment.
Main Methods:
- Retrospective analysis of 107 patients diagnosed with PSP according to MDS 2017 criteria.
- Patients categorized into YOPSP and LOPSP based on a 65-year age cutoff.
- Phenotypes, symptoms, MDS core criteria, and disease severity (PSP-RS) were compared.
Main Results:
- YOPSP patients showed a higher prevalence of the PSP speech/language (SL) phenotype (18% vs 0%) and aphasia (16% vs 1.4%).
- Speech and language dysfunction (C1) was more common in YOPSP (33.3% vs 12.2%).
- Longitudinal PSP-RS data indicated a faster worsening of the bulbar score in YOPSP at 6 months.
Conclusions:
- Young-onset PSP is frequently associated with a speech and language variant.
- Age of onset is a potential predictor of PSP phenotypes, with significant clinical and prognostic implications.
Related Concept Videos
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K

